5 February 2025 in JACC: Clinical Electrophysiology
MAMikkel Porsborg Andersen
CTChristian Torp-Pedersen
+2
4 December 2025 in European Heart Journal
Background and Aims: Diabetes mellitus is associated with increased risk of sudden cardiac death (SCD). However, nationwide, unselected studies are lacking. Therefore, this study aimed to estimate the incidence rates of SCD among individuals with Type 1 diabetes (T1D) and Type 2 diabetes (T2D) and to quantify the shortened life expectancy that can be attributed to SCD. Methods: The study included the entire Danish population in 2010. Sudden cardiac death cases were identified through the detailed Danish death certificates, and discharge summaries, and if performed, autopsy reports. Cox proportional hazards models were used to estimate risk of SCD in diabetes patients. Loss of life years was estimated for both T1D and T2D patients. Results: Among the identified 6862 SCD cases, 97 were diagnosed with T1D and 1149 with T2D. Incidence rates of SCD were 3.7 times higher for T1D and 6.5 times higher for T2D compared with the general population. After multivariable adjustment, both T1D and T2D were independently associated with SCD. The greatest risk difference was observed in younger individuals with diabetes. Life-years lost were on average 14.2 and 7.9 years shorter for patients with T1D and T2D, respectively. A reduced life expectancy of 3.4 and 2.7 years was found to be attributed to SCD for T1D and T2D, respectively. Conclusions: Individuals with diabetes displayed consistently elevated incidence rates of SCD across age groups. Further, the elevated risk of SCD in individuals with diabetes diminished with increasing age. For both T1D and T2D, SCD was an important contributing factor to shortened life expectancy.
21 November 2025 in Indian Pacing and Electrophysiology Journal
Sudden cardiac death (SCD) is accountable for 10-20% of deaths in Europe. While inherited and acquired structural heart disease underlie a considerable proportion, many SCDs remain unexplained after conventional autopsy. Lack of structural cardiac abnormalities in sudden death points towards the possibility of inherited heart disease, yet to manifest in observable changes. In fact, 70 % of SCDs in the young are potentially inherited, and causes may be familial hypercholesterolemia, cardiomyopathies, and primary arrhythmias syndromes. Early diagnosis of occult hereditary conditions and initiation of tailored prevention is key in risk reduction of SCD in relatives of deceased individuals. Postmortem genetic testing is recommended in potential inherited causes of SCD, with novel data showing the technique enables detection of concealed cardiomyopathies and channelopathies. Yet widespread implementation is impeded by a number of challenges, including lack of awareness among clinicians of the value of postmortem genetics. Current guidelines from the European Society of Cardiology (ESC) and the American Heart Association (AHA) advise both post-mortem genetic testing of the SCD victim with a potential inherited cause of death and testing of first-degree relatives to prevent future SCDs. Furthermore, it is recommended that specialists interpret findings, and that family evaluation takes place in multidisciplinary collaboration between cardiologists, pathologists, geneticists, and counsellors. This review provides a summary of contemporary knowledge on SCD, outlines guidelines for general forensic management and use of post-mortem genetic testing - including its interpretation, advantages, and challenges - and finally describes standard procedures for investigations of relatives to the deceased individual.
17 January 2025 in EP Europace
Aims: The aim of this study was to examine differences in incidence rates of all-cause mortality (ACM) and sudden cardiac death (SCD) in persons of differing socio-economic position (SEP). Methods and results: All deaths in Denmark from 1 January to 31 December 2010 (1 year) were included. Autopsy reports, death certificates, discharge summaries, and nationwide health registries were reviewed to identify cases of SCD. Socio-economic position was measured as either household income or highest achieved educational level and analysed separately. Hazard rates were calculated using univariate and multivariable Cox regression models adjusting for age, sex, and selected comorbidities. A total of 53 452 deaths were included, of which 6820 were classified as SCDs. Incidence rates of ACM and SCD increased with age and were higher in the lower SEP groups. The greatest difference in SCD incidence was found between the low and high education level groups, with an incidence rate ratio of 5.1 (95% confidence interval 3.8–6.8). The hazard ratios for ACM and SCD were significantly higher for low SEP groups, independent of comorbidities. Compared with the highest income group, the low-income group had adjusted hazard ratios of ACM and SCD that were 2.17 (2.01–2.34) and 1.72 (1.67–1.76), respectively. Conclusion: We observed an inverse association between both income and education level and the risk of ACM and SCD in the general population, which persisted independently of baseline comorbidities. Our results indicate a need for further research into the mechanisms behind socio-economic disparities in healthcare and targeted preventative strategies.
17 December 2025 in Heart